MetAlert (OTC: MLRT), a pioneer in the field of wearable GPS human and asset tracking and remote patient monitoring, has launched its award-winning wearable medical monitoring device in the Canadian market through distributor Red Dot Alerts. MLRT’s 4G GPS SmartSole is integrated into an orthotic insole, enabling location data to be gathered remotely and discreetly. As part of the launch, the company unveiled a media campaign including radio and magazine ads along with mailers sent to medical clinics, hospitals, pharmacies, and senior residence facilities across Canada. The campaign promotes the “game-changing” device, which monitors individuals who may wander off and get lost. Committed to helping people live independent and safe lives, Red Dot Alerts is Canada’s only personal-alert solution company; the company offers a range of custom products including the GPS SmartSole. MetAlert also recognized the recent launch of the Advanced Research Projects Agency for Health (“ARPA-H”) at the National Institutes of Health, which is investing a billion dollars in cutting-edge research for Alzheimer’s. “Insurance or government financial assistance is a key component in helping families address the costs associated with caring for someone with Alzheimer’s or dementia,” said MetAlert CEO Patrick Bertagna in the press release. “Qualifying GPS SmartSole customers can receive assistance from Medicaid programs, using our National Provider Identifier: 1447709290. And similar reimbursement programs have been initiated for the GPS SmartSole in other countries such as Canada, the U.K. and Norway, so we are very excited to hear about additional funding becoming available through this new ARPA-H program the administration has launched with a billion-dollar commitment.”
To view the full press release, visit https://ibn.fm/PWYzw
About MetAlert Inc.
MetAlert, a pioneer in smart, mobile, and wearable tracking and recovery location-based solutions, is supported through a proprietary IoT enterprise monitoring platform and intellectual property portfolio. The company offers a global end-to-end solution of hardware, software and connectivity and develops two-way GPS tracking technologies, which seamlessly integrate with consumer products and enterprise applications. Utilizing the latest in miniaturized, low-power consumption GPS, cellular, RF, NFC and BLE technology, MetAlert products enable subscribers to track in real time the whereabouts of people or high-value assets. Known for its game-changing and award-winning patented GPS SmartSole — think Dr. Scholl’s meets LoJack, the world’s first invisible, wearable, technology-tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism or traumatic brain injury. MetAlert’s business model is built around technology innovation and holds dozens of patents, with many issued patents in the area of GPS tracking. The company has international distributors servicing customers across the globe with subscribers in more than 40 countries; MetAlert is also a U.S. military government contractor. Other customers include public health authorities and municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers. For more information about this company, please visit www.MetAlert.com
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
